```

[Federal Register Volume 88, Number 207 (Friday, October 27, 2023)]
[Proposed Rules]
[Pages 73766-73767]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-23701]

=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

10 CFR Part 35

[NRC-2018-0297]
RIN 3150-AK80

Rubidium-82 Generators, Emerging Technologies, and Other Medical 
Use of Byproduct Material; Extension of Comment Period

AGENCY: Nuclear Regulatory Commission.

ACTION: Regulatory basis; extension of comment period.

-----------------------------------------------------------------------

SUMMARY: On July 3, 2023, the U.S. Nuclear Regulatory Commission (NRC) 
solicited comments on the regulatory basis for the planned rulemaking 
on ``Rubidium-82 Generators, Emerging Technologies, and Other Medical 
Use of Byproduct Material.'' The public comment period was originally 
scheduled to close on October 31, 2023. The NRC has decided to extend 
the public comment period to allow more time for members of the public 
to develop and submit their comments.

DATES: The due date of comments requested in the document published on 
July 3, 2023 (88 FR 42654) is extended. Comments should be filed no 
later than December 15, 2023. Comments received after this date will be 
considered, if it is practical to do so, but the NRC is able to ensure 
consideration only for comments received on or before this date.

ADDRESSES: You may submit comments by any of the following methods; 
however, the NRC encourages electronic comment submission through the 
Federal rulemaking website:
     Federal Rulemaking website: Go to https://www.regulations.gov and search for Docket ID NRC-2018-0297. Address 
questions about NRC dockets to Dawn Forder; telephone: 301-415-3407; 
email: [email protected]. For technical questions contact the 
individuals listed in the FOR FURTHER INFORMATION CONTACT section of 
this document.
     Email comments to: [email protected]. If you do 
not receive an automatic email reply confirming receipt, then contact 
us at 301-415-1677.
     Fax comments to: Secretary, U.S. Nuclear Regulatory 
Commission at 301-415-1101.
     Mail comments to: Secretary, U.S. Nuclear Regulatory 
Commission, Washington, DC 20555-0001, ATTN: Rulemakings and 
Adjudications Staff.
     Hand deliver comments to: 11555 Rockville Pike, Rockville, 
Maryland 20852, between 7:30 a.m. and 4:15 p.m. eastern time, Federal 
workdays; telephone: 301-415-1677.
    For additional direction on obtaining information and submitting 
comments, see ``Obtaining Information and Submitting Comments'' in the 
SUPPLEMENTARY INFORMATION section of this document.

FOR FURTHER INFORMATION CONTACT: Andrew Carrera, Office of Nuclear 
Material Safety and Safeguards, telephone: 301-415-1078, email: 
[email protected]; and Maryann Ayoade, Office of Nuclear Material 
Safety and Safeguards, telephone: 301-415-0862, email: 
[email protected]. Both are staff of the U.S. Nuclear Regulatory 
Commission, Washington, DC 20555-0001.

SUPPLEMENTARY INFORMATION: 

I. Obtaining Information and Submitting Comments

A. Obtaining Information

    Please refer to Docket ID NRC-2018-0297 when contacting the NRC 
about the availability of information for this action. You may obtain 
publicly available information related to this action by any of the 
following methods:
     Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2018-0297.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly available documents online in the 
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``Begin Web-based ADAMS 
Search.'' For problems with ADAMS, please contact the NRC's Public 
Document Room (PDR) reference staff at 1-800-397-4209, at 301-415-4737, 
or by email to [email protected]. The ADAMS accession number for 
each document referenced (if it is available in ADAMS) is provided the 
first time that it is mentioned in this document.
     NRC's PDR: The PDR, where you may examine and order copies 
of publicly available documents, is open by appointment. To make an 
appointment to visit the PDR, please send an email to 
[email protected] or call 1-800-397-4209 or 301-415-4737, between 8 
a.m. and 4 p.m. eastern time, Monday through Friday, except Federal 
holidays.

B. Submitting Comments

    The NRC encourages electronic comment submission through the 
Federal Rulemaking website (https://

[[Page 73767]]

www.regulations.gov). Please include Docket ID NRC-2018-0297 in your 
comment submission.
    The NRC cautions you not to include identifying or contact 
information that you do not want to be publicly disclosed in your 
comment submission. The NRC will post all comment submissions at 
https://www.regulations.gov as well as enter the comment submissions 
into ADAMS. The NRC does not routinely edit comment submissions to 
remove identifying or contact information.
    If you are requesting or aggregating comments from other persons 
for submission to the NRC, then you should inform those persons not to 
include identifying or contact information that they do not want to be 
publicly disclosed in their comment submission. Your request should 
state that the NRC does not routinely edit comment submissions to 
remove such information before making the comment submissions available 
to the public or entering the comment into ADAMS.

II. Discussion

    On July 3, 2023, the NRC solicited comments on the regulatory basis 
for a planned rulemaking on ``Rubidium-82 Generators, Emerging 
Technologies, and Other Medical Use of Byproduct Material.'' The public 
comment period was originally scheduled to close on October 31, 2023. 
By letter dated October 19, 2023 (ADAMS Accession No. ML23292A176), the 
Mercurie Consulting, LLC; American Association of Physicist in 
Medicine; American College of Radiology; American Society of Radiation 
Oncology; and Society of Nuclear Medicine and Medical Imaging requested 
that the NRC extend the comment period by 45 days. The NRC has decided 
to grant this request and extend the public comment period on this 
document until December 15, 2023, to allow more time for members of the 
public to submit their comments.
    The NRC may post materials related to this document, including 
public comments, on the Federal rulemaking website at https://www.regulations.gov under Docket ID NRC-2018-0297. In addition, the 
Federal rulemaking website allows members of the public to receive 
alerts when changes or additions occur in a docket folder. To 
subscribe: (1) navigate to the docket folder (NRC-2018-0297); (2) click 
the ``Subscribe'' link; and (3) enter an email address and click on the 
``Subscribe'' link.

    Dated: October 23, 2023.

    For the Nuclear Regulatory Commission.
Catherine E. Kanatas,
Acting Deputy Director, Division of Rulemaking, Environmental, and 
Financial Support, Office of Nuclear Material Safety and Safeguards.
[FR Doc. 2023-23701 Filed 10-26-23; 8:45 am]
BILLING CODE 7590-01-P
```